Ziming C. Dong

No.100 Kexue Road
Zhengzhou, 450001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 95 publications

Diosmetin alleviates the immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma by dually inhibiting angiogenesis and promoting CD8+T cell cytotoxicity.

Diosmetin alleviates the immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma by dually inhibiting angiogenesis and promoting CD8+T cell cytotoxicity.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: December 19, 2025

PDIA6 promotes the cell proliferation of ESCC by enhancing the disulfide bond formation in TRAF4.

PDIA6 promotes the cell proliferation of ESCC by enhancing the disulfide bond formation in TRAF4.

Journal: Cellular & molecular biology letters

Published: September 08, 2025

JAK3/STAT5A-dependent IL-8 regulation drives ESCC angiogenesis and is suppressed by dihydroartemisinin.

JAK3/STAT5A-dependent IL-8 regulation drives ESCC angiogenesis and is suppressed by dihydroartemisinin.

Journal: International immunopharmacology

Published: April 10, 2025

Selection and identification of DNA aptamer binding VDAC1 for tumor tissue imaging and targeted drug delivery.

Selection and identification of DNA aptamer binding VDAC1 for tumor tissue imaging and targeted drug delivery.

Journal: International journal of biological macromolecules

Published: December 25, 2024

SRPK1 Activation Facilitates Gli3S664 Phosphorylation and Promotes Metastasis in Esophageal Squamous Cell Carcinoma.

SRPK1 Activation Facilitates Gli3S664 Phosphorylation and Promotes Metastasis in Esophageal Squamous Cell Carcinoma.

Journal: Molecular carcinogenesis

Published: July 15, 2024

p38 mediated ACSL4 phosphorylation drives stress-induced esophageal squamous cell carcinoma growth through Src myristoylation.

p38 mediated ACSL4 phosphorylation drives stress-induced esophageal squamous cell carcinoma growth through Src myristoylation.

Journal: Nature communications

Published: December 30, 2023

A novel Fc-enhanced humanized monoclonal antibody targeting B7-H3 suppresses the growth of ESCC.

A novel Fc-enhanced humanized monoclonal antibody targeting B7-H3 suppresses the growth of ESCC.

Journal: Oncoimmunology

Published: December 21, 2023

Domperidone inhibits cell proliferation via targeting MEK and CDK4 in esophageal squamous cell carcinoma.

Domperidone inhibits cell proliferation via targeting MEK and CDK4 in esophageal squamous cell carcinoma.

Journal: Cancer cell international

Published: November 24, 2023

Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3β/TCF7/MMP9 pathway and synergies with capecitabine.

Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3β/TCF7/MMP9 pathway and synergies with capecitabine.

Journal: Cancer letters

Published: July 17, 2023

PHGDH promotes esophageal squamous cell carcinoma progression via Wnt/β-catenin pathway.

PHGDH promotes esophageal squamous cell carcinoma progression via Wnt/β-catenin pathway.

Journal: Cellular signalling

Published: February 23, 2023

TOPK promotes the growth of esophageal cancer in vitro and in vivo by enhancing YB1/eEF1A1 signal pathway.

TOPK promotes the growth of esophageal cancer in vitro and in vivo by enhancing YB1/eEF1A1 signal pathway.

Journal: Cell death & disease

Published: November 20, 2022

PGC-1α promotes colorectal carcinoma metastasis through regulating ABCA1 transcription.

PGC-1α promotes colorectal carcinoma metastasis through regulating ABCA1 transcription.

Journal: Oncogene

Published: October 21, 2022

Showing 1-12 of 95

Last Updated: 09/26/2026